{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:25:48Z","timestamp":1771863948408,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902727"],"award-info":[{"award-number":["81902727"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2022JJ40781"],"award-info":[{"award-number":["2022JJ40781"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-022-01984-3","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T09:03:21Z","timestamp":1670835801000},"page":"1361-1371","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of a novel nomogram predicting pseudohypoxia type pheochromocytomas and paragangliomas"],"prefix":"10.1007","volume":"46","author":[{"given":"Y.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0173-7883","authenticated-orcid":false,"given":"X.","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"issue":"3","key":"1984_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","volume":"28","author":"AK Lam","year":"2017","unstructured":"Lam AK (2017) Update on adrenal Tumours in 2017 world health organization (WHO) of Endocrine Tumours. Endocr Pathol 28(3):213\u2013227. https:\/\/doi.org\/10.1007\/s12022-017-9484-5","journal-title":"Endocr Pathol"},{"issue":"3","key":"1984_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s12020-022-03205-6","volume":"78","author":"M Jensterle","year":"2022","unstructured":"Jensterle M, Podbregar A, Janez A, Rakusa M, Goricar K, Prokselj K (2022) Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease. Endocrine 78(3):580\u2013586. https:\/\/doi.org\/10.1007\/s12020-022-03205-6","journal-title":"Endocrine"},{"issue":"1","key":"1984_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.hoc.2015.09.006","volume":"30","author":"L Fishbein","year":"2016","unstructured":"Fishbein L (2016) Pheochromocytoma and paraganglioma: genetics, diagnosis, and treatment. Hematol Oncol Clin North Am 30(1):135\u2013150. https:\/\/doi.org\/10.1016\/j.hoc.2015.09.006","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"1984_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4158\/EP-2017-0057","volume":"24","author":"LB Mercado-Asis","year":"2018","unstructured":"Mercado-Asis LB, Wolf KI, Jochmanova I, Taieb D (2018) Pheochromocytoma: a genetic and diagnostic update. Endocr Pract 24(1):78\u201390. https:\/\/doi.org\/10.4158\/EP-2017-0057","journal-title":"Endocr Pract"},{"issue":"R2","key":"1984_CR5","doi-asserted-by":"publisher","first-page":"R128","DOI":"10.1093\/hmg\/ddaa201","volume":"29","author":"R Casey","year":"2020","unstructured":"Casey R, Neumann HPH, Maher ER (2020) Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicine. Hum Mol Genet 29(R2):R128\u2013R137. https:\/\/doi.org\/10.1093\/hmg\/ddaa201","journal-title":"Hum Mol Genet"},{"issue":"8","key":"1984_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3390\/medicina58081113","volume":"58","author":"A Provenzano","year":"2022","unstructured":"Provenzano A, Chetta M, De Filpo G, Cantini G, La Barbera A, Nesi G, Santi R, Martinelli S, Rapizzi E, Luconi M, Maggi M, Mannelli M, Ercolino T, Canu L (2022) Novel germline PHD2 variant in a metastatic pheochromocytoma and chronic myeloid leukemia, but in the absence of polycythemia. Medicina (Kaunas) 58(8):1113. https:\/\/doi.org\/10.3390\/medicina58081113","journal-title":"Medicina (Kaunas)"},{"issue":"4","key":"1984_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/cancers11040436","volume":"11","author":"Y Pang","year":"2019","unstructured":"Pang Y, Liu Y, Pacak K, Yang C (2019) Pheochromocytomas and paragangliomas: from genetic diversity to targeted therapies. Cancers (Basel). 11(4):436. https:\/\/doi.org\/10.3390\/cancers11040436","journal-title":"Cancers (Basel)."},{"issue":"1","key":"1984_CR8","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1080\/07853890.2021.1956687","volume":"53","author":"W Pipitprapat","year":"2021","unstructured":"Pipitprapat W, Pattanaprateep O, Iemwimangsa N, Sensorn I, Panthan B, Jiaranai P, Chantratita W, Sorapipatcharoen K, Poomthavorn P, Mahachoklertwattana P, Sura T, Tunteeratum A, Srichan K, Sriphrapradang C (2021) Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma. Ann Med 53(1):1243\u20131255. https:\/\/doi.org\/10.1080\/07853890.2021.1956687","journal-title":"Ann Med"},{"key":"1984_CR9","doi-asserted-by":"publisher","first-page":"677983","DOI":"10.3389\/fonc.2021.677983","volume":"11","author":"F Sesti","year":"2021","unstructured":"Sesti F, Feola T, Puliani G, Centello R, Di Vito V, Bagni O, Lenzi A, Isidori AM, Cantisani V, Faggiano A, Giannetta E (2021) Sunitinib treatment for advanced paraganglioma: case report of a novel SDHD gene mutation variant and systematic review of the literature. Front Oncol 11:677983. https:\/\/doi.org\/10.3389\/fonc.2021.677983","journal-title":"Front Oncol"},{"key":"1984_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fendo.2020.00234","volume":"11","author":"C Pozza","year":"2020","unstructured":"Pozza C, Sesti F, Di Dato C, Sbardella E, Pofi R, Schiavi F, Bonifacio V, Isidori AM, Faggiano A, Lenzi A, Giannetta E (2020) A novel MAX gene mutation variant in a patient with multiple and \u201ccomposite\u201d neuroendocrine-neuroblastic Tumors. Front Endocrinol (Lausanne) 11:234. https:\/\/doi.org\/10.3389\/fendo.2020.00234","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1984_CR11","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac058","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li M, Pang Y, Wang C, Wu J, Cheng Z, Li X, Lu Z, Liu Y, Guo J, Chen X, He Y, Guan X, Xu X, Wang Y, Liu J, Guo W, Hou Y, Liu L, Jiang J, Gao X (2022) Genetic characteristics of incidental pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgac058","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1984_CR12","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1210\/clinem\/dgaa502","volume":"105","author":"J Jiang","year":"2020","unstructured":"Jiang J, Zhang J, Pang Y, Bechmann N, Li M, Monteagudo M, Calsina B, Gimenez-Roqueplo AP, Nolting S, Beuschlein F, Fassnacht M, Deutschbein T, Timmers H, Akerstrom T, Crona J, Quinkler M, Fliedner SMJ, Liu Y, Guo J, Li X, Guo W, Hou Y, Wang C, Zhang L, Xiao Q, Liu L, Gao X, Burnichon N, Robledo M, Eisenhofer G (2020) Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 105(10):3295. https:\/\/doi.org\/10.1210\/clinem\/dgaa502","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1984_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3390\/jpm11111239","volume":"11","author":"B Winzeler","year":"2021","unstructured":"Winzeler B, Challis BG, Casey RT (2021) Precision medicine in phaeochromocytoma and paraganglioma. J Pers Med. 11(11):1239. https:\/\/doi.org\/10.3390\/jpm11111239","journal-title":"J Pers Med."},{"issue":"2","key":"1984_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS, Cancer Genome Atlas Research N, Pacak K, Nathanson KL, Wilkerson MD (2017) Cancer genome atlas research comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31(2):181\u2013193. https:\/\/doi.org\/10.1016\/j.ccell.2017.01.001","journal-title":"Cancer Cell"},{"issue":"2","key":"1984_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/endrev\/bnab019","volume":"43","author":"S Nolting","year":"2022","unstructured":"Nolting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, Eisenhofer G, Grossman A, Pacak K (2022) Personalized management of pheochromocytoma and paraganglioma. Endocr Rev 43(2):199\u2013239. https:\/\/doi.org\/10.1210\/endrev\/bnab019","journal-title":"Endocr Rev"},{"issue":"6","key":"1984_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00062","volume":"38","author":"J Crona","year":"2017","unstructured":"Crona J, Taieb D, Pacak K (2017) New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification. Endocr Rev 38(6):489\u2013515. https:\/\/doi.org\/10.1210\/er.2017-00062","journal-title":"Endocr Rev"},{"issue":"12","key":"1984_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/jmedgenet-2012-101192","volume":"49","author":"LT van Hulsteijn","year":"2012","unstructured":"van Hulsteijn LT, Dekkers OM, Hes FJ, Smit JW, Corssmit EP (2012) Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis. J Med Genet 49(12):768\u2013776. https:\/\/doi.org\/10.1136\/jmedgenet-2012-101192","journal-title":"J Med Genet"},{"issue":"3","key":"1984_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4158\/EP15725.OR","volume":"22","author":"H Turkova","year":"2016","unstructured":"Turkova H, Prodanov T, Maly M, Martucci V, Adams K, Widimsky J Jr, Chen CC, Ling A, Kebebew E, Stratakis CA, Fojo T, Pacak K (2016) Characteristics and outcomes of metastatic sdhb and sporadic pheochromocytoma\/paraganglioma: an national institutes of health study. Endocr Pract 22(3):302\u2013314. https:\/\/doi.org\/10.4158\/EP15725.OR","journal-title":"Endocr Pract"},{"issue":"5","key":"1984_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/ERC-19-0024","volume":"26","author":"J Crona","year":"2019","unstructured":"Crona J, Lamarca A, Ghosal S, Welin S, Skogseid B, Pacak K (2019) Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis. Endocr Relat Cancer 26(5):539\u2013550. https:\/\/doi.org\/10.1530\/ERC-19-0024","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"1984_CR20","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1210\/jc.2018-02411","volume":"104","author":"Buffet A, Ben Aim L, Leboulleux S, Drui D, Vezzosi D, Libe R, Ajzenberg C, Bernardeschi D, Cariou B, Chabolle F, Chabre O, Darrouzet V, Delemer B, Desailloud R, Goichot B, Esvant A, Offredo L, Herman P, Laboureau S, Lefebvre H, Pierre P, Raingeard I, Reznik Y, Sadoul J L, Hadoux J, Tabarin A, Tauveron I, Zenaty D, Favier J, Bertherat J, Baudin E, Amar L, Gimenez-Roqueplo A P, French Group of Endocrine T, and Network C","year":"2019","unstructured":"Buffet A, Ben Aim L, Leboulleux S, Drui D, Vezzosi D, Libe R, Ajzenberg C, Bernardeschi D, Cariou B, Chabolle F, Chabre O, Darrouzet V, Delemer B, Desailloud R, Goichot B, Esvant A, Offredo L, Herman P, Laboureau S, Lefebvre H, Pierre P, Raingeard I, Reznik Y, Sadoul J L, Hadoux J, Tabarin A, Tauveron I, Zenaty D, Favier J, Bertherat J, Baudin E, Amar L, Gimenez-Roqueplo A P, French Group of Endocrine T, and Network C (2019) Positive impact of genetic test on the management and outcome of patients with paraganglioma and\/or pheochromocytoma. J Clin Endocrinol Metab 104(4):1109\u20131118. https:\/\/doi.org\/10.1210\/jc.2018-02411","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1984_CR21","doi-asserted-by":"publisher","first-page":"E1248","DOI":"10.1210\/jc.2013-1319","volume":"98","author":"E Rattenberry","year":"2013","unstructured":"Rattenberry E, Vialard L, Yeung A, Bair H, McKay K, Jafri M, Canham N, Cole TR, Denes J, Hodgson SV, Irving R, Izatt L, Korbonits M, Kumar AV, Lalloo F, Morrison PJ, Woodward ER, Macdonald F, Wallis Y, Maher ER (2013) A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 98(7):E1248\u2013E1256. https:\/\/doi.org\/10.1210\/jc.2013-1319","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1984_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jmoldx.2017.04.009","volume":"19","author":"M Curras-Freixes","year":"2017","unstructured":"Curras-Freixes M, Pineiro-Yanez E, Montero-Conde C, Apellaniz-Ruiz M, Calsina B, Mancikova V, Remacha L, Richter S, Ercolino T, Rogowski-Lehmann N, Deutschbein T, Calatayud M, Guadalix S, Alvarez-Escola C, Lamas C, Aller J, Sastre-Marcos J, Lazaro C, Galofre JC, Patino-Garcia A, Meoro-Aviles A, Balmana-Gelpi J, De Miguel-Novoa P, Balbin M, Matias-Guiu X, Leton R, Inglada-Perez L, Torres-Perez R, Roldan-Romero JM, Rodriguez-Antona C, Fliedner SMJ, Opocher G, Pacak K, Korpershoek E, de Krijger RR, Vroonen L, Mannelli M, Fassnacht M, Beuschlein F, Eisenhofer G, Cascon A, Al-Shahrour F, Robledo M (2017) PheoSeq: a targeted next-generation sequencing assay for pheochromocytoma and paraganglioma diagnostics. J Mol Diagn 19(4):575\u2013588. https:\/\/doi.org\/10.1016\/j.jmoldx.2017.04.009","journal-title":"J Mol Diagn"},{"issue":"7","key":"1984_CR23","doi-asserted-by":"publisher","first-page":"E1352","DOI":"10.1210\/jc.2013-4375","volume":"99","author":"J Welander","year":"2014","unstructured":"Welander J, Andreasson A, Juhlin CC, Wiseman RW, Backdahl M, Hoog A, Larsson C, Gimm O, Soderkvist P (2014) Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 99(7):E1352\u2013E1360. https:\/\/doi.org\/10.1210\/jc.2013-4375","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1984_CR24","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1245\/s10434-022-11419-1","volume":"29","author":"JJ Baechle","year":"2022","unstructured":"Baechle JJ, Smith PM, Ortega CA, Wang TS, Solorzano CC, Kiernan CM (2022) Clinical Predictors of Pseudohypoxia-Type Pheochromocytomas. Ann Surg Oncol 29(6):3536\u20133546. https:\/\/doi.org\/10.1245\/s10434-022-11419-1","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1984_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.soc.2015.08.006","volume":"25","author":"CM Kiernan","year":"2016","unstructured":"Kiernan CM, Solorzano CC (2016) Pheochromocytoma and paraganglioma: diagnosis, genetics, and treatment. Surg Oncol Clin N Am 25(1):119\u2013138. https:\/\/doi.org\/10.1016\/j.soc.2015.08.006","journal-title":"Surg Oncol Clin N Am"},{"issue":"34","key":"1984_CR26","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","volume":"23","author":"L Amar","year":"2005","unstructured":"Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23(34):8812\u20138818. https:\/\/doi.org\/10.1200\/JCO.2005.03.1484","journal-title":"J Clin Oncol"},{"issue":"8","key":"1984_CR27","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26(8):1364\u20131370. https:\/\/doi.org\/10.1200\/JCO.2007.12.9791","journal-title":"J Clin Oncol"},{"key":"1984_CR28","doi-asserted-by":"publisher","first-page":"770958","DOI":"10.3389\/fonc.2022.770958","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, Abbas KS, Abdelazeem B, Xu Y, Lin Y, Wu H, Chekhonin VP, Peltzer K, Zhang C (2022) A predictive nomogram for early death in pheochromocytoma and paraganglioma. Front Oncol 12:770958. https:\/\/doi.org\/10.3389\/fonc.2022.770958","journal-title":"Front Oncol"},{"key":"1984_CR29","doi-asserted-by":"publisher","first-page":"882906","DOI":"10.3389\/fendo.2022.882906","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen D, Pang Y, Xu X, Guan X, Liu L (2022) Value of immunohistochemical expression of apelin, succinate dehydrogenase B, chromogranin B, human epidermal growth factor receptor-2, contactin 4, and succinyl-CoA synthetase subunit beta in differentiating metastatic from non-metastatic pheochromocytoma and paraganglioma. Front Endocrinol (Lausanne) 13:882906. https:\/\/doi.org\/10.3389\/fendo.2022.882906","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1984_CR30","doi-asserted-by":"publisher","first-page":"m997","DOI":"10.1136\/bmj.m997","volume":"369","author":"Y Li","year":"2020","unstructured":"Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H, Shi B, Sun H, Ba J, Chen B, Du J, He L, Lai X, Li Y, Chi H, Liao E, Liu C, Liu L, Tang X, Tong N, Wang G, Zhang JA, Wang Y, Xue Y, Yan L, Yang J, Yang L, Yao Y, Ye Z, Zhang Q, Zhang L, Zhu J, Zhu M, Ning G, Mu Y, Zhao J, Teng W, Shan Z (2020) Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American diabetes association: national cross sectional study. BMJ 369:m997. https:\/\/doi.org\/10.1136\/bmj.m997","journal-title":"BMJ"},{"issue":"7","key":"1984_CR31","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/cancers11070936","volume":"11","author":"D Mamilla","year":"2019","unstructured":"Mamilla D, Araque KA, Brofferio A, Gonzales MK, Sullivan JN, Nilubol N, Pacak K (2019) Postoperative management in patients with pheochromocytoma and paraganglioma. Cancers (Basel). 11(7):936. https:\/\/doi.org\/10.3390\/cancers11070936","journal-title":"Cancers (Basel)."},{"issue":"17","key":"1984_CR32","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/jnci\/djt201","volume":"105","author":"I Jochmanova","year":"2013","unstructured":"Jochmanova I, Yang C, Zhuang Z, Pacak K (2013) Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst 105(17):1270\u20131283. https:\/\/doi.org\/10.1093\/jnci\/djt201","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"1984_CR33","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/ijc.28868","volume":"135","author":"N Qin","year":"2014","unstructured":"Qin N, de Cubas AA, Garcia-Martin R, Richter S, Peitzsch M, Menschikowski M, Lenders JW, Timmers HJ, Mannelli M, Opocher G, Economopoulou M, Siegert G, Chavakis T, Pacak K, Robledo M, Eisenhofer G (2014) Opposing effects of HIF1alpha and HIF2alpha on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X. Int J Cancer 135(9):2054\u20132064. https:\/\/doi.org\/10.1002\/ijc.28868","journal-title":"Int J Cancer"},{"issue":"1","key":"1984_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.surg.2017.05.025","volume":"163","author":"P Nockel","year":"2018","unstructured":"Nockel P, El Lakis M, Gaitanidis A, Yang L, Merkel R, Patel D, Nilubol N, Prodanov T, Pacak K, Kebebew E (2018) Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery. Surgery 163(1):191\u2013196. https:\/\/doi.org\/10.1016\/j.surg.2017.05.025","journal-title":"Surgery"},{"issue":"3","key":"1984_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/cancers13030385","volume":"13","author":"V Seifert","year":"2021","unstructured":"Seifert V, Richter S, Bechmann N, Bachmann M, Ziegler CG, Pietzsch J, Ullrich M (2021) HIF2alpha-associated pseudohypoxia promotes radioresistance in pheochromocytoma: insights from 3D models. Cancers (Basel). 13(3):385. https:\/\/doi.org\/10.3390\/cancers13030385","journal-title":"Cancers (Basel)."},{"key":"1984_CR36","doi-asserted-by":"publisher","first-page":"722656","DOI":"10.3389\/fendo.2021.722656","volume":"12","author":"J Marz","year":"2021","unstructured":"Marz J, Kurlbaum M, Roche-Lancaster O, Deutschbein T, Peitzsch M, Prehn C, Weismann D, Robledo M, Adamski J, Fassnacht M, Kunz M, Kroiss M (2021) Plasma metabolome profiling for the diagnosis of catecholamine producing Tumors. Front Endocrinol (Lausanne) 12:722656. https:\/\/doi.org\/10.3389\/fendo.2021.722656","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01984-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01984-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01984-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T09:22:06Z","timestamp":1686561726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01984-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["1984"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01984-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"11 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Medical Ethics Committee of Xiangya Hospital (202204090), Central South University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consents were obtained from all patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors had full access to all the data in the study and accept responsibility to submit for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}